# name
Budd-Chiari syndrome with short-length stenosis: still room for the angioplasty and wait-and-see strategy

# metadata.dc.description.abstract[].value
We read with interest the study in The Lancet Gastroenterology & Hepatology by Qiuhe Wang and colleagues. 1 This randomised controlled trial aimed to elucidate whether routine stenting plus angioplasty was superior to angioplasty alone for preventing restenosis in patients with Budd-Chiari syndrome with short-length stenosis. The authors found that patients treated with angioplasty plus routine stenting had a lower incidence of restenosis than did patients treated with angioplasty alone, with no differences in survival. Based on these findings, the authors suggested that stenting combined with angioplasty should be used as a first-line invasive treatment in patients with Budd-Chiari syndrome with short-length stenosis.

# metadata.dc.relation.ispartof[].value
The Lancet Gastroenterology & Hepatology, 2019, vol. 4, num. 11, p. 823

# metadata.dc.source[].value
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

# metadata.dc.title[].value
Budd-Chiari syndrome with short-length stenosis: still room for the angioplasty and wait-and-see strategy